Dental Bone Graft And Substitutes

Dental Bone Graft And Substitutes Market Outlook

The global dental bone graft and substitutes market is projected to reach approximately USD 3.2 billion by 2035, growing at a compound annual growth rate (CAGR) of around 7% during the forecast period from 2025 to 2035. The growth of this market can be attributed to the increasing prevalence of dental diseases, a rising demand for cosmetic dentistry, and advancements in dental implant technologies. Furthermore, the growing awareness regarding oral health and hygiene among the global population is leading to higher adoption rates of bone grafting procedures. The expansion of dental services in developing regions, coupled with an increase in dental tourism, is also expected to contribute significantly to market growth during the forecast period. Additionally, technological advancements in grafting materials and techniques are enhancing the effectiveness of these procedures, thereby boosting their adoption in various dental applications.

Growth Factor of the Market

One of the primary growth factors for the dental bone graft and substitutes market is the increasing incidence of dental disorders, such as periodontal disease and tooth loss, which necessitate bone grafting procedures for restoration and rehabilitation. Alongside this, the rising population of aging individuals globally, who are more susceptible to dental conditions, is further propelling market demand. Moreover, the surge in cosmetic dental procedures fueled by the desire for aesthetically pleasing smiles is paving the way for increased use of bone grafts, particularly in dental implants and ridge augmentation. The advancements in biomaterials and the development of novel synthetic grafts are also enhancing the efficiency and safety of dental surgical procedures, leading to a broader acceptance and application of these products. Furthermore, the increasing investment in oral healthcare infrastructure, especially in emerging economies, is expected to create substantial growth opportunities for dental graft and substitute manufacturers.

Key Highlights of the Market

• The dental bone graft and substitutes market is projected to reach USD 3.2 billion by 2035.
• Growth is driven by an increasing prevalence of dental diseases and a demand for cosmetic procedures.
• Technological advancements in grafting materials enhance procedure effectiveness.
• The market is expected to witness significant growth in developing regions due to expanding dental services.
• Investment in oral healthcare infrastructure is creating new opportunities for manufacturers.

By Product Type

Allografts:

Allografts are bone grafts obtained from human donors and are widely used in dental surgeries due to their natural integration properties. These grafts are advantageous as they provide a scaffold for new bone formation while eliminating the need for additional surgical sites, thereby minimizing patient discomfort and recovery time. The allograft segment holds a significant share in the dental bone graft market as they have been proven effective in various applications, including dental implants and periodontal surgeries. The increasing acceptance of allografts in dental practices, largely due to their biocompatibility and minimal risk of disease transmission, is bolstering their demand. Furthermore, the ongoing research and developments in allograft processing techniques are enhancing the safety and efficacy of these products, contributing to market growth.

Xenografts:

Xenografts are derived from animal sources, primarily bovine, and are utilized in dental bone grafting procedures. Their popularity stems from their ability to provide an excellent scaffold for bone regeneration while being readily available and cost-effective. Xenografts are particularly favored for their osteoconductive properties, supporting new bone formation effectively. The segment is witnessing steady growth due to the increasing number of dental surgeries and advancements in processing methods that enhance their safety profiles. Additionally, xenografts are often used in combination with other grafting materials, providing a synergistic effect that further supports bone healing, hence driving their adoption in various dental applications.

Synthetic Bone Grafts:

Synthetic bone grafts are gaining traction in the dental bone graft market owing to their customizable properties and the ability to avoid the risks associated with biological grafts. These grafts, made from materials such as hydroxyapatite and calcium phosphate, replicate the natural bone structure and provide an effective scaffold for new bone growth. The increasing preference for synthetic grafts is attributed to their availability, predictable outcomes, and reduced risk of disease transmission. As these materials are biocompatible and can be tailored to suit specific needs, they are widely utilized in diverse dental applications, including implants and socket preservation. The ongoing innovations in synthetic graft materials continue to enhance their performance and widen their application range, thereby propelling market growth.

Demineralized Bone Matrix:

Demineralized Bone Matrix (DBM) is a product derived from human or animal bone that has undergone a process to remove minerals, thus preserving the organic bone structure. DBM is widely recognized for its osteoinductive properties, which promote the formation of new bone tissue by stimulating the body's natural healing processes. Its unique characteristics make it a preferred choice for various dental applications, including ridge augmentation and periodontal defect repair. The growing acceptance of DBM in dental surgeries, coupled with its ability to provide significant benefits in bone regeneration, is contributing to its increasing market share. Additionally, the advancements in processing techniques are enhancing the safety and effectiveness of DBM, making it a favorable option for dental professionals.

Bone Graft Substitutes:

Bone graft substitutes are synthetic or natural materials designed to replace or augment bone tissues in dental procedures. These substitutes offer several advantages, including reduced risk of complications compared to traditional bone grafts, as well as the ability to customize properties based on specific patient needs. The rising number of dental implant surgeries and the demand for minimally invasive procedures are significantly driving the use of bone graft substitutes. Moreover, the continuous research and development in this segment are leading to innovations that improve the performance and applicability of these substitutes in diverse dental applications. As dental professionals increasingly seek effective alternatives to traditional grafting materials, the segment of bone graft substitutes is witnessing notable growth within the market.

By Application

Dental Implants:

The application of dental implants is one of the most significant segments in the dental bone graft and substitutes market. Dental implants require adequate bone volume and density for successful integration with the jawbone; hence, bone grafts are often utilized to augment bone levels prior to implant placement. The rising prevalence of tooth loss and the growing awareness of dental aesthetics are propelling the demand for dental implants, consequently stimulating the need for grafting materials. As technology advances, the techniques related to dental implants and bone grafting procedures are becoming more sophisticated, which enhances success rates and patient satisfaction. The increasing number of dental professionals adopting these technologies is further driving the segment's growth.

Ridge Augmentation:

Ridge augmentation is a surgical procedure that aims to rebuild the bone ridge in the jaw where teeth have been lost. This application is crucial for patients who wish to receive dental implants but lack sufficient bone mass. Bone graft materials are essential for successful ridge augmentation, and the increasing demand for dental implants is significantly contributing to the growth of this segment. Additionally, the rise in awareness regarding the importance of maintaining oral structure integrity and aesthetics is encouraging more patients to consider ridge augmentation procedures. The advancements in grafting techniques and materials are also improving the outcomes of these procedures, ensuring a higher success rate for patients undergoing ridge augmentation.

Socket Preservation:

Socket preservation is a technique employed following tooth extraction to maintain the alveolar bone's volume and structure. By utilizing bone grafts or substitutes, dental professionals can prevent bone resorption and ensure successful future implant placement. This application is becoming increasingly important as more patients opt for tooth extraction and subsequent dental implants. The growing awareness among patients about the benefits of socket preservation, coupled with advancements in surgical techniques, is driving the demand for grafting materials in this segment. Moreover, as the focus on preventive care increases within dentistry, socket preservation procedures are expected to gain more traction, further contributing to market growth.

Periodontal Defect:

Periodontal defect treatment is another critical application of dental bone grafts and substitutes. These defects occur due to periodontal disease, resulting in the loss of bone around teeth. The use of bone graft materials is essential in restoring the lost bone and supporting the healing process. The rising prevalence of periodontal diseases, largely fueled by lifestyle factors such as poor oral hygiene and smoking, is driving demand within this application. Additionally, advancements in regenerative techniques and materials are improving the effectiveness of treatment options available for periodontal defects. As more patients seek solutions for periodontal diseases, the utilization of bone grafts in this context is expected to increase, further enhancing market growth.

By End User

Hospitals:

Hospitals represent a significant end-user segment in the dental bone graft and substitutes market. They often have advanced facilities and a higher volume of patients undergoing dental surgeries, including those requiring bone grafts. The availability of specialized dental departments within hospitals allows for comprehensive care, including pre-operative assessments and post-operative follow-ups. As the awareness regarding oral health grows and more patients seek restorative dental procedures, hospitals are increasingly equipped to handle complex cases that involve dental bone grafting. This trend is further supported by the integration of advanced surgical techniques and technologies in hospital settings, which enhances patient outcomes and satisfaction, ultimately driving demand for bone graft materials.

Dental Clinics:

Dental clinics are also a prominent end-user segment for dental bone grafts and substitutes, as they provide specialized services for dental health and restoration. With the rise in cosmetic dentistry and the increasing number of patients opting for dental implants, dental clinics are witnessing a surge in demand for bone grafting procedures. The accessibility of these clinics and the personalized care they offer make them a preferred choice for many patients seeking dental treatment. Moreover, the growing trend of minimally invasive procedures is prompting dental professionals to adopt advanced grafting techniques and materials, which are helping to enhance treatment outcomes. As a result, the dental clinic segment is expected to experience notable growth, contributing significantly to the overall market expansion.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining popularity as an end-user segment in the dental bone graft and substitutes market due to their ability to provide outpatient surgical procedures efficiently and effectively. These centers offer a cost-effective alternative for patients requiring dental surgeries, including those involving bone grafts. The convenience of ASCs, combined with the rising demand for quick and effective dental procedures, is driving the growth of this segment. Additionally, advancements in surgical techniques and technology allow ASCs to provide high-quality care, resulting in improved patient satisfaction. As patients increasingly opt for outpatient procedures, the role of ambulatory surgical centers in the dental bone graft market is expected to expand significantly.

By Material Type

Hydroxyapatite:

Hydroxyapatite is a widely used material in dental bone grafts and substitutes due to its similarity to natural bone mineral composition. Its biocompatibility and osteoconductive properties make it an ideal choice for various dental applications, including implants and periodontal defect treatments. The use of hydroxyapatite in grafting procedures enhances the integration of the graft with the host bone, promoting successful healing and restoration. The segment is witnessing growth driven by the rising demand for effective and safe grafting materials among dental professionals and patients alike. Continuous innovations in hydroxyapatite formulations are enhancing its effectiveness, leading to an increase in its adoption in dental surgeries.

Calcium Phosphate:

Calcium phosphate is another prominent material type used in dental bone grafts due to its excellent biocompatibility and ability to promote bone regeneration. It exists in various forms, including tricalcium phosphate, which is often utilized in grafting procedures. Calcium phosphate materials facilitate new bone formation by providing a conducive environment for cell proliferation and differentiation. The increasing preference for calcium phosphate in dental applications is primarily driven by its favorable properties, including osteoconductivity and resorption rates, which are crucial for successful grafting outcomes. As research continues to explore the optimal formulations and applications of calcium phosphate, its presence in the dental bone graft market is anticipated to expand significantly.

Collagen:

Collagen is gaining traction as a material type in dental bone grafts due to its natural origin and ability to promote cell adhesion and proliferation. As a structural protein, collagen provides an essential scaffold for bone regeneration, which enhances the healing process in various dental applications. The increasing demand for biocompatible and biodegradable materials in dental surgeries is driving the growth of this segment. Moreover, collagen-based grafts are often utilized in combination with other materials to improve their overall effectiveness, leading to a more significant application in complex procedures such as periodontal defect repair and socket preservation. The continuous advancements in collagen processing and formulation are further enhancing its performance and potential within the dental bone graft market.

Tricalcium Phosphate:

Tricalcium phosphate (TCP) is a synthetic material frequently utilized in dental bone grafting due to its excellent osteoconductive properties and resorption capabilities. TCP plays a crucial role in promoting new bone formation while gradually being replaced by natural bone over time. The growing acceptance of TCP in dental applications is driven by its effectiveness in various procedures, including dental implants and ridge augmentation. Additionally, the ability to customize TCP formulations to meet specific patient needs makes it an attractive option for dental professionals. As research continues to explore the optimal applications and formulations of TCP, its role in the dental bone graft market is expected to expand, supporting its increasing popularity.

Others:

Other materials utilized in dental bone grafts and substitutes include various synthetic compounds and bioactive glass, which are increasingly being adopted for their unique properties. These materials are often engineered to provide superior biocompatibility, mechanical strength, and bioactivity, enhancing their effectiveness in supporting bone regeneration. The demand for alternative materials stems from the need for customizable solutions that cater to individual patient requirements and specific clinical scenarios. As advancements in material science continue to unveil new options, the segment of other materials in the dental bone graft market is expected to grow, offering dental professionals a broader range of choices for their patients.

By Region

The dental bone graft and substitutes market is experiencing significant growth across various regions, driven by the increasing prevalence of dental diseases and the rising demand for cosmetic dental procedures. In North America, the market is projected to maintain its dominance, accounting for over 40% of the global market share. The region benefits from advanced healthcare infrastructure, high disposable income, and a growing awareness of oral health issues among consumers. Moreover, the presence of established dental product manufacturers and continuous innovations in grafting materials are further propelling growth in this region, with a CAGR of approximately 6.5% anticipated during the forecast period.

In Europe, the dental bone graft market is also witnessing substantial growth, driven by rising dental procedures and investments in dental healthcare. The region is characterized by a strong focus on research and development, leading to the introduction of innovative grafting materials and techniques. The Asia Pacific region is expected to exhibit the highest growth rate, with a projected CAGR of over 8% during the forecast period. This growth can be attributed to the increasing population, rising disposable incomes, and expanding access to dental care in emerging countries. Additionally, the growing awareness regarding oral health and aesthetics among the population is further boosting demand for dental bone grafts in Asia Pacific.

Opportunities

The dental bone graft and substitutes market is poised for significant opportunities, largely driven by the increasing global emphasis on oral health and wellness. As the population ages and the prevalence of dental issues rises, there is a growing demand for effective and restorative dental procedures that require bone grafting. This trend creates opportunities for manufacturers to innovate and expand their product offerings to meet the evolving needs of dental professionals and patients. Furthermore, the rising popularity of cosmetic dentistry presents a lucrative opportunity for market players, as more individuals seek aesthetic enhancements, leading to a higher demand for advanced grafting materials and techniques.

Moreover, emerging markets present significant growth opportunities for the dental bone graft and substitutes market. Countries in Asia Pacific, Latin America, and the Middle East are experiencing rapid economic development, resulting in increased access to dental care and rising consumer spending on oral health. Manufacturers can capitalize on this trend by establishing strategic partnerships with local dental practices and investing in marketing efforts to create awareness about the benefits of bone grafting procedures. Additionally, the ongoing research and development efforts aimed at creating innovative materials and technologies promise to open up new avenues for growth in the market, allowing companies to stay ahead of the competition and meet patient demands effectively.

Threats

Despite the promising growth prospects, the dental bone graft and substitutes market faces several threats that could impede its progress. One of the primary challenges is the availability of alternative treatment options, such as guided tissue regeneration and non-grafting techniques, which may deter some professionals from opting for bone grafting procedures. As patients become more informed about their choices, the preference for less invasive procedures could impact the demand for dental bone grafts and substitutes. Additionally, strict regulatory requirements and lengthy approval processes for new grafting materials can pose challenges for manufacturers seeking to introduce innovative products into the market, potentially delaying their entry and affecting market dynamics.

Another significant threat to the market is the growing concern regarding the safety and efficacy of grafting materials, especially those derived from biological sources. Patients may be apprehensive about the risk of disease transmission associated with allografts and xenografts, leading to a reluctance to undergo procedures involving these materials. Furthermore, the increasing prevalence of counterfeit or substandard products in the market can negatively impact patient trust and safety. To mitigate these threats, stakeholders in the dental bone graft and substitutes market must prioritize transparency, quality assurance, and rigorous testing to establish credibility and enhance patient confidence in their products.

Competitor Outlook

• Zimmer Biomet Holdings, Inc.
• DePuy Synthes
• Medtronic plc
• Heraeus Kulzer GmbH
• BoneSupport AB
• LifeNet Health
• Dentsply Sirona Inc.
• Geistlich Pharma AG
• Osstem Implant Co., Ltd.
• Straumann Holding AG
• Biomaterials Technologies, Inc.
• ACE Surgical Supply Co., Inc.
• RTI Surgical Holdings, Inc.
• Implant Direct (a subsidiary of Danaher Corporation)
• Collagen Matrix, Inc.

The competitive landscape of the dental bone graft and substitutes market is characterized by a mix of established players and emerging companies that are continually innovating to gain market share. Major companies are focusing on expanding their product portfolios, investing in research and development, and forming strategic partnerships to enhance their market presence. The competition is further intensified by the emphasis on technological advancements in grafting materials and techniques, providing opportunities for companies to differentiate themselves through superior product offerings. As dental professionals increasingly seek effective solutions for grafting procedures, the competition among market players is expected to grow, driving innovation and improving patient outcomes.

Zimmer Biomet Holdings, Inc. is a leading player in the dental bone graft market, offering a wide range of grafting materials and devices designed to support dental restoration and rehabilitation. The company's focus on research and development has led to the introduction of innovative products that cater to the evolving needs of dental professionals. Their advanced grafting solutions, combined with a strong distribution network, have positioned them as a key player in the competitive landscape. Additionally, Medtronic plc is another prominent company in the market, known for its advanced biomaterials and surgical technologies that enhance the effectiveness of bone grafting procedures. Medtronic continues to invest in expanding its product offerings and improving patient outcomes through innovative solutions.

Dentsply Sirona Inc. is also a significant competitor, recognized for its comprehensive portfolio of dental products, including bone graft substitutes and regenerative materials. The company has a strong presence in both the dental and surgical markets, leveraging its expertise to develop high-quality grafting solutions. Furthermore, Geistlich Pharma AG specializes in regenerative dentistry and has established itself as a trusted brand for bone grafting materials. Their commitment to research and development, combined with a focus on quality and safety, has allowed them to maintain a competitive edge in the market. As these companies continue to innovate and adapt to changing consumer demands, the dental bone graft and substitutes market is expected to witness sustained growth and evolution.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 DePuy Synthes
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 BoneSupport AB
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 LifeNet Health
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Geistlich Pharma AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Heraeus Kulzer GmbH
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Dentsply Sirona Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Straumann Holding AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Collagen Matrix, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Osstem Implant Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 RTI Surgical Holdings, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Zimmer Biomet Holdings, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 ACE Surgical Supply Co., Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Biomaterials Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Implant Direct (a subsidiary of Danaher Corporation)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Dental Bone Graft And Substitutes Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Dental Clinics
    • 6.1.3 Ambulatory Surgical Centers
  • 6.2 Dental Bone Graft And Substitutes Market, By Application
    • 6.2.1 Dental Implants
    • 6.2.2 Ridge Augmentation
    • 6.2.3 Socket Preservation
    • 6.2.4 Periodontal Defect
  • 6.3 Dental Bone Graft And Substitutes Market, By Product Type
    • 6.3.1 Allografts
    • 6.3.2 Xenografts
    • 6.3.3 Synthetic Bone Grafts
    • 6.3.4 Demineralized Bone Matrix
    • 6.3.5 Bone Graft Substitutes
  • 6.4 Dental Bone Graft And Substitutes Market, By Material Type
    • 6.4.1 Hydroxyapatite
    • 6.4.2 Calcium Phosphate
    • 6.4.3 Collagen
    • 6.4.4 Tricalcium Phosphate
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Dental Bone Graft And Substitutes Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Dental Bone Graft And Substitutes market is categorized based on

By Product Type

• Allografts
• Xenografts
• Synthetic Bone Grafts
• Demineralized Bone Matrix
• Bone Graft Substitutes

By Application

• Dental Implants
• Ridge Augmentation
• Socket Preservation
• Periodontal Defect

By End User

• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers

By Material Type

• Hydroxyapatite
• Calcium Phosphate
• Collagen
• Tricalcium Phosphate
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zimmer Biomet Holdings, Inc.
• DePuy Synthes
• Medtronic plc
• Heraeus Kulzer GmbH
• BoneSupport AB
• LifeNet Health
• Dentsply Sirona Inc.
• Geistlich Pharma AG
• Osstem Implant Co., Ltd.
• Straumann Holding AG
• Biomaterials Technologies, Inc.
• ACE Surgical Supply Co., Inc.
• RTI Surgical Holdings, Inc.
• Implant Direct (a subsidiary of Danaher Corporation)
• Collagen Matrix, Inc.